Tate & Lyle PLC
Holding(s) in Company
Tate & Lyle PLC (the 'Company') was informed on 10 December 2004 that, as a
result of the sale by Compagnie Industrielle et Financiere des Produits Amylaces
S.A. ('CIP') of 48,350,000 ordinary shares of 25 pence each ('ordinary shares')
in the Company, Archer Daniels Midland Company ('ADM') has now ceased for the
purposes of Part VI of the Companies Act 1985 to be interested in 48,350,000
ordinary shares in the Company.
As announced on 16 August 2000, ADM had previously reported an interest in
75,851,086 ordinary shares in the Company which at that date was 15.75 per cent.
of the ordinary share capital. This interest included CIP's interest at that
date in 48,083,913 ordinary shares in the Company.
Accordingly, ADM has informed the Company it now has an interest in 27,872,173
ordinary shares in the Company which is 5.74 per cent. of the ordinary share
capital. These shares are registered in the name of ISI Nominees Ltd.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.